The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: gemcitabine     Quarter: 2016Q3

Total Records: 1,060     Number of Pages: 53

DRUGNAME PT EventCount
GEMCITABINE Full blood count decreased 2
GEMCITABINE Gamma-glutamyltransferase increased 2
GEMCITABINE Gastroenteritis radiation 2
GEMCITABINE Gastrointestinal ulcer haemorrhage 2
GEMCITABINE Gouty arthritis 2
GEMCITABINE Graft versus host disease 2
GEMCITABINE Guillain-Barre syndrome 2
GEMCITABINE Haematochezia 2
GEMCITABINE Haemoptysis 2
GEMCITABINE Hepatic enzyme increased 2
GEMCITABINE Hepatic infection 2
GEMCITABINE Hepatocellular injury 2
GEMCITABINE Hydrocephalus 2
GEMCITABINE Hyperadrenocorticism 2
GEMCITABINE Hyperbilirubinaemia 2
GEMCITABINE Hypertrophic cardiomyopathy 2
GEMCITABINE Hypoaesthesia 2
GEMCITABINE Hypoalbuminaemia 2
GEMCITABINE Hypocalcaemia 2
GEMCITABINE Hypoglycaemia 2

Total Records: 1,060     Number of Pages: 53